Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 15117K103 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Bpifrance Participations SA
13D/A
Amendment 6
|
11.1% |
12/12/2025
Event 12/3/2025
|
|
| Bpifrance Participations S.A. | 10.0% | ||
| Caisse des Depots | 11.1% | ||
| CDC Croissance S.A. | 1.1% | ||
| EPIC Bpifrance | 10.0% | ||
| Bpifrance S.A. | 10.0% | ||
|
Long Focus Capital Management, LLC
13G/A
Amendment 3
|
4.6% |
2/11/2025
Event 12/31/2024
|
|
| Long Focus Capital Management, LLC | 4.6% | ||
| Long Focus Capital Master, Ltd. | 2.5% | ||
| Condagua, LLC | 2.1% | ||
| John Helmers | 4.6% | ||
| Glenn Helmers | 2.1% | ||
|
Bpifrance Participations SA
13D/A
Amendment 5
|
13.1% |
1/30/2025
Event 1/30/2025
|
|
| Bpifrance Participations S.A. | 11.8% | ||
| Caisse des Depots | 13.1% | ||
| CDC Croissance S.A. | 1.3% | ||
| EPIC Bpifrance | 11.8% | ||
| Bpifrance S.A. | 11.8% | ||
|
AstraZeneca PLC
13D/A
Amendment 2
|
44.0% |
1/24/2025
Event 1/23/2025
|
|
| AstraZeneca PLC | 44.0% | ||
| AstraZeneca Holdings B.V. | 44.0% |
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 35.0 k | $52.9 k |
| 2026 Q2 | 27 | 9.48 M | $28.4 M |
| 2026 Q1 | 32 | 10.2 M | $32.5 M |
| 2025 Q4 | 34 | 10.5 M | $51.1 M |
| 2025 Q3 | 31 | 8.32 M | $23.7 M |
| 2025 Q2 | 25 | 11.8 M | $17.9 M |
| 2025 Q1 | 28 | 13.6 M | $16.9 M |
| 2024 Q4 | 32 | 12.8 M | $23.0 M |
| 2024 Q3 | 31 | 9.77 M | $20.9 M |
| 2024 Q2 | 33 | 9.86 M | $18.4 M |
| 2024 Q1 | 36 | 10.0 M | $26.6 M |
| 2023 Q4 | 42 | 9.89 M | $30.5 M |
| 2023 Q3 | 35 | 11.5 M | $18.1 M |
| 2023 Q2 | 40 | 14.0 M | $27.6 M |
| 2023 Q1 | 35 | 15.2 M | $29.3 M |
| 2022 Q4 | 43 | 8.73 M | $18.3 M |
| 2022 Q3 | 52 | 10.3 M | $23.6 M |
| 2022 Q2 | 47 | 10.8 M | $30.7 M |
| 2022 Q1 | 57 | 12.4 M | $56.4 M |
| 2021 Q4 | 66 | 15.2 M | $127 M |
| 2021 Q3 | 75 | 15.4 M | $194 M |
| 2021 Q2 | 84 | 16.3 M | $253 M |
| 2021 Q1 | 87 | 15.3 M | $310 M |
| 2020 Q4 | 99 | 16.4 M | $464 M |
| 2020 Q3 | 77 | 14.3 M | $264 M |
| 2020 Q2 | 82 | 13.9 M | $247 M |
| 2020 Q1 | 72 | 15.7 M | $145 M |
| 2019 Q4 | 64 | 13.2 M | $227 M |
| 2019 Q3 | 65 | 13.1 M | $137 M |
| 2019 Q2 | 82 | 13.9 M | $217 M |
| 2019 Q1 | 66 | 12.7 M | $234 M |
| 2018 Q4 | 68 | 11.5 M | $191 M |
| 2018 Q3 | 86 | 11.5 M | $326 M |
| 2018 Q2 | 92 | 11.3 M | $319 M |
| 2018 Q1 | 74 | 7.07 M | $223 M |
| 2017 Q4 | 63 | 7.31 M | $213 M |
| 2017 Q3 | 49 | 5.87 M | $167 M |
| 2017 Q2 | 46 | 5.26 M | $136 M |
| 2017 Q1 | 45 | 5.74 M | $138 M |
| 2016 Q4 | 43 | 5.80 M | $98.2 M |
| 2016 Q3 | 40 | 6.64 M | $160 M |
| 2016 Q2 | 39 | 6.96 M | $185 M |
| 2016 Q1 | 44 | 6.47 M | $178 M |
| 2015 Q4 | 48 | 7.05 M | $219 M |
| 2015 Q3 | 44 | 7.10 M | $187 M |
| 2015 Q2 | 40 | 6.60 M | $238 M |
| 2015 Q1 | 44 | 6.12 M | $212 M |